DNA‑Encoded Library (DEL) Technology segmentation by type distinguishes solid‑phase, solution‑phase, and microfluidic platforms, each with sub‑categories that affect cost, scalability, and data fidelity. Solid‑phase DELs anchor DNA tags to resin beads, enabling parallel synthesis of DNA‑tagged small molecules and DNA‑tagged macrocycles; this approach dominates the market due to its compatibility with existing combinatorial chemistry infrastructure, contributing an estimated 60 % of type‑related revenue. Solution‑phase DELs keep the DNA tag in suspension, facilitating the synthesis of DNA‑encoded fragments and DNA‑encoded natural product analogues; the flexibility of reaction conditions makes this type responsible for roughly 30 % of market value, particularly in academic collaborations. Microfluidic DELs integrate nanoliter‑scale reactors with on‑chip sequencing, supporting DNA‑encoded peptide and DNA‑encoded covalent‑binder libraries; while still emerging, this niche accounts for about 10 % of type‑specific sales, driven by lower reagent consumption and accelerated turnaround times. The proportional revenue distribution reflects the maturity and adoption rate of each technology class.